Showing results (241-250 of 252) with videos related to
Sort By:
Pageof 26
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.American Journal of Hematology|April 2, 2024
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO studyMatthieu Groh, Laurène Fenwarth, Mathilde Labro, et al.The Lancet. Rheumatology|January 22, 2024
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 studyGrégoire Martin de Frémont, Nathalie Costedoat-Chalumeau, Estibaliz Lazaro, et al.Proceedings of the National Academy of Sciences of the United States of America|April 22, 2025
Horizontal transfer of nuclear DNA in transmissible cancerKevin Gori, Adrian Baez-Ortega, Andrea Strakova, et al.ESMO Open|September 26, 2020
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysisEvandro de Azambuja, Mariana Brandão, Hans Wildiers, et al.Haematologica|April 20, 2023
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 studyAlexis Talbot, Arthur Bobin, Léa Tabone, et al.Allergy|January 6, 2025
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter CohortGuillaume Lefèvre, Séverine Bleuse, Mathieu Puyade, et al.Gastrointestinal Endoscopy|October 25, 2023
Western outcomes of circumferential endoscopic submucosal dissection for early esophageal squamous cell carcinomaEnrique Rodríguez de Santiago, Laurelle van Tilburg, Pierre H Deprez, et al.Nature Medicine|June 3, 2024
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trialXavier Leleu, Cyrille Hulin, Jerome Lambert, et al.The Journal of Allergy and Clinical Immunology. in Practice|September 24, 2025
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic SyndromeRomain Stammler, Alexandre Vallée, Julien Rohmer, et al.Pageof 26